First marketing authorization submission for blarcamesine NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of ...

Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...

Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...

As the global population ages, the importance of understanding neurological disorders increases exponentially. Two ...

Parkinson's drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of bacteria ...

The use of PD Neurotechnology's pioneering telemonitoring device to assess Parkinson's Disease (PD) symptoms and inform ...

Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras as a potential adjunctive treatment for Parkinson's ...

In 2019, Blair shared with her Instagram followers that she was undergoing a hematopoietic stem cell transplantation, or HSCT ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...